Ocugen (OCGN) Net Income towards Common Stockholders (2014 - 2026)

Ocugen has reported Net Income towards Common Stockholders for 13 years, with the latest figure at -$19.2 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 24.93% year-over-year to -$19.2 million; the trailing twelve-month figure through Mar 2026 stood at -$54.0 million (up 22.14% YoY), and the FY2024 full-year result was -$54.0 million, up 14.38% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$19.2 million, up from -$20.1 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was -$11.0 million in Q4 2023, with the low at -$54.0 million in Q4 2024.
• Historically, Net Income towards Common Stockholders has averaged -$21.7 million across 5 years, with a median of -$19.6 million in 2025.
• Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders surged 50.0% — and 2024, when it tumbled 391.92%.
• Ocugen's Net Income towards Common Stockholders stood at -$21.9 million in 2022, then surged by 50.0% to -$11.0 million in 2023, then plunged by 391.92% to -$54.0 million in 2024, then soared by 62.84% to -$20.1 million in 2025, then grew by 4.36% to -$19.2 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$19.2 million (Q1 2026), -$20.1 million (Q3 2025), and -$14.7 million (Q2 2025), per Business Quant data.